Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:United_States_federal_law
|
| gptkbp:affects |
pharmaceutical companies
medical device manufacturers clinical trial sponsors |
| gptkbp:amendedBy |
gptkb:Federal_Food,_Drug,_and_Cosmetic_Act
|
| gptkbp:category |
gptkb:United_States_federal_health_legislation
2007 in American law |
| gptkbp:citation |
gptkb:121_Stat._823
|
| gptkbp:containsProvision |
Food safety
ClinicalTrials.gov registration requirements Expanded authority for postmarket safety Pediatric Medical Device Safety Risk Evaluation and Mitigation Strategies User Fee Reauthorization |
| gptkbp:dateEnacted |
September 27, 2007
|
| gptkbp:enactedBy |
gptkb:United_States_Congress
|
| https://www.w3.org/2000/01/rdf-schema#label |
FDA Amendments Act of 2007
|
| gptkbp:publicLawNumber |
gptkb:Public_Law_110-85
|
| gptkbp:regulates |
gptkb:Food_and_Drug_Administration
|
| gptkbp:shortName |
gptkb:FDAAA
|
| gptkbp:signedBy |
gptkb:George_W._Bush
|
| gptkbp:bfsParent |
gptkb:REMS
|
| gptkbp:bfsLayer |
6
|